Tag Archives: Request letter

Junshi Biotechnology was questioned by the Shanghai Stock Exchange about the new crown neutralizing antibody in collaboration with Eli Lilly

[ad_1] Original title: Junshi Biologics was interrogated by the Shanghai Stock Exchange, involving the new crown neutralizing antibody in collaboration with Eli Lilly On the evening of November 12, ShanghaiJunshi BiomedicinalTechnological actionsLimited copiesthe company(Junshi Bio, 688180) releasedadHe said the same day he received theJunshi BioStocks of pharmaceutical technologyLimited Liability CompanyInquiry …

Read More »